| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |